MGMT and female reproductive organ cancer: About 8 of 29 included studies presented significant association between hypermethylation of MGMT promoter and risk of breast and gynecological cancers in women16,18,21,23,28,29,31,32, whereas all of the remaining suggested no significant relationship12–17,19,20,22,24–27,30,33–39.